Semaglutide is a type 2 diabetes treatment originally which revealed its potential to be effective in the case of weight loss in other patients than diabetes. 1. Significant Weight Loss According to the results of clinical trials, using semaglutide,...
The U.S. Food and Drug Administration (FDA) has just given a green light for new medicine for chronic weight management. Here are the main factors in this development: 1. Drug Name and Class The approved medicine is Wegovy (semaglutide), a glucagon-like...
Obesity is strongly linked with Being overweight/BMI and 2-Diabetes both of these terms are not closely related to each other but when looked in a scope or a lens that is accustomed to seeing and understanding the mechanisms specific as fat mass and blood glucose...
Impact of Semaglutide on Cardiovascular Outcomes in Obese Persons Obesity remains a global health challenge, which is defined as an abnormal or excessive accumulation of body fat to the extent that one’s health may be affected. Obesity increases the risk of various...
The use of GLP-1 receptor agonists in medicine has viaducted a number of zigs and zags in their history. It has been a roller-coaster of therapeutic applications from the timeline of GLP-1 receptor agonists. Original Purpose: To treat type 2 diabetes, these...
Join our community to receive the latest updates on prescription weight loss medications and tips for maintaining a healthy lifestyle. Subscribe now to never miss an update!